A prospective evaluation of thromboelastometry (ROTEM) to identify acute traumatic coagulopathy and predict massive transfusion in military trauma patients in Afghanistan.


Journal

Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360

Informations de publication

Date de publication:
04 2019
Historique:
received: 18 09 2018
revised: 14 01 2019
accepted: 14 01 2019
entrez: 14 4 2019
pubmed: 14 4 2019
medline: 27 8 2019
Statut: ppublish

Résumé

Hemorrhage is the leading cause of preventable trauma-related mortality and is frequently aggravated by acute traumatic coagulopathy (ATC). Viscoelastic tests such as rotational thromboelastometry (ROTEM) may improve identification and management of ATC. This study aimed to prospectively evaluate changes in ROTEM among combat casualties during the first 24 hours and compare the capabilities of our conventional clotting assay (international normalized ratio [INR], >1.2) to a proposed integrated ROTEM model (INR >1.2 with the addition of tissue factor pathway activation thromboelastometry [EXTEM] A5 ≤35 mm and/or EXTEM LI30 <97% on admission) to identify ATC and predict massive transfusion (MT). This was a prospective observational study of trauma patients treated in NATO hospitals in Afghanistan between January 2012 and June 2013. ROTEM (EXTEM, functional fibrinogen thromboelastometry, APTEM, EXTEM with the addition of a fibrinolysis inhibitor) was performed on admission and at 6 and 24 hours by a designated research team. Treatment teams did not have access to the ROTEM results. ROTEM values were available for 40 male casualties. The integrated ROTEM model classified 15% more patients with ATC than with INR alone and increased the detection of those that required MT by 22%. The sensitivity of the integrated ROTEM model to predict MT was higher than with INR greater than 1.2 (86% vs. 64%); however, specificity with both definitions for predicting MT was poor (38% vs. 50%, respectively). These observations support the importance of early identification of and intervention in ATC. Integrating ROTEM into the definition of ATC would increase detection of those requiring MT arguing for its use as an adjunct to clinical presentation in the ultimate decision to initiate MT.

Sections du résumé

BACKGROUND
Hemorrhage is the leading cause of preventable trauma-related mortality and is frequently aggravated by acute traumatic coagulopathy (ATC). Viscoelastic tests such as rotational thromboelastometry (ROTEM) may improve identification and management of ATC. This study aimed to prospectively evaluate changes in ROTEM among combat casualties during the first 24 hours and compare the capabilities of our conventional clotting assay (international normalized ratio [INR], >1.2) to a proposed integrated ROTEM model (INR >1.2 with the addition of tissue factor pathway activation thromboelastometry [EXTEM] A5 ≤35 mm and/or EXTEM LI30 <97% on admission) to identify ATC and predict massive transfusion (MT).
STUDY DESIGN AND METHODS
This was a prospective observational study of trauma patients treated in NATO hospitals in Afghanistan between January 2012 and June 2013. ROTEM (EXTEM, functional fibrinogen thromboelastometry, APTEM, EXTEM with the addition of a fibrinolysis inhibitor) was performed on admission and at 6 and 24 hours by a designated research team. Treatment teams did not have access to the ROTEM results.
RESULTS
ROTEM values were available for 40 male casualties. The integrated ROTEM model classified 15% more patients with ATC than with INR alone and increased the detection of those that required MT by 22%. The sensitivity of the integrated ROTEM model to predict MT was higher than with INR greater than 1.2 (86% vs. 64%); however, specificity with both definitions for predicting MT was poor (38% vs. 50%, respectively).
CONCLUSION
These observations support the importance of early identification of and intervention in ATC. Integrating ROTEM into the definition of ATC would increase detection of those requiring MT arguing for its use as an adjunct to clinical presentation in the ultimate decision to initiate MT.

Identifiants

pubmed: 30980751
doi: 10.1111/trf.15176
doi:

Types de publication

Clinical Trial Comparative Study Journal Article Multicenter Study Observational Study Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Pagination

1601-1607

Informations de copyright

© 2019 AABB.

Auteurs

Jared Cohen (J)

Department of Internal Medicine, Aviano Air Force Base, Aviano, Italy.

Thomas Scorer (T)

Centre of Defence Pathology, RCDM, Birmingham, UK.
University of Bristol, Bristol, UK.
Coagulation and Blood Research Program, US Army Institute of Surgical Research, FT Sam Houston, Texas.

Zachary Wright (Z)

Department of Oncology and Hematology, Keesler Air Force Base, Keesler, Biloxi, Mississippi.

Ian J Stewart (IJ)

David Grant USAF Medical Center, Clinical Investigation Facility, Fairfield, California.

Jonathan Sosnov (J)

Department of Nephrology, Scott Air Force Base, Scott, Illinois.

Heather Pidcoke (H)

Cellphire Inc, Rockville, Maryland.

Chriselda Fedyk (C)

Coagulation and Blood Research Program, US Army Institute of Surgical Research, FT Sam Houston, Texas.

Hana Kwan (H)

Department of Nephrology, Joint Base San Antonio, Fort Sam Houston, Texas.

Kevin K Chung (KK)

Department of Medicine, Uniformed Services University, Bethesda Maryland.

Kelly Heegard (K)

Carolina Nephrology, Greenville, South Carolina.

Christopher White (C)

Brooke Army Medical Centre, JBSA-Fort Sam Houston, Texas.

Andrew Cap (A)

Coagulation and Blood Research Program, US Army Institute of Surgical Research, FT Sam Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH